Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.

Solassol J, Vendrell J, Märkl B, Haas C, Bellosillo B, Montagut C, Smith M, O'Sullivan B, D'Haene N, Le Mercier M, Grauslund M, Melchior LC, Burt E, Cotter F, Stieber D, Schmitt FL, Motta V, Lauricella C, Colling R, Soilleux E, Fassan M, Mescoli C, Collin C, Pagès JC, Sillekens P.

PLoS One. 2016 Sep 29;11(9):e0163444. doi: 10.1371/journal.pone.0163444. eCollection 2016.

2.

Evaluation of different nucleic acid amplification techniques for the detection of M. pneumoniae, C. pneumoniae and Legionella spp. in respiratory specimens from patients with community-acquired pneumonia.

Loens K, Beck T, Ursi D, Overdijk M, Sillekens P, Goossens H, Ieven M.

J Microbiol Methods. 2008 Jun;73(3):257-62. doi: 10.1016/j.mimet.2008.02.010. Epub 2008 Mar 10.

PMID:
18378345
3.
4.

Development of conventional and real-time NASBA for the detection of Legionella species in respiratory specimens.

Loens K, Beck T, Goossens H, Ursi D, Overdijk M, Sillekens P, Ieven M.

J Microbiol Methods. 2006 Dec;67(3):408-15. Epub 2006 May 30.

PMID:
16730822
5.
7.

Sensitivity of detection of rhinoviruses in spiked clinical samples by nucleic acid sequence-based amplification in the presence of an internal control.

Loens K, Ieven M, Pattyn S, Sillekens P, Goossens H.

J Microbiol Methods. 2006 Jul;66(1):73-8. Epub 2005 Nov 28.

PMID:
16318891
8.

Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR.

Keightley MC, Sillekens P, Schippers W, Rinaldo C, George KS.

J Med Virol. 2005 Dec;77(4):602-8.

PMID:
16254971
9.

Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid.

Ginocchio CC, Zhang F, Malhotra A, Manji R, Sillekens P, Foolen H, Overdyk M, Peeters M.

J Clin Microbiol. 2005 Jun;43(6):2616-23.

10.

Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum.

Schneider P, Wolters L, Schoone G, Schallig H, Sillekens P, Hermsen R, Sauerwein R.

J Clin Microbiol. 2005 Jan;43(1):402-5.

11.

Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.

Goossens VJ, Christiaans MH, Blok MJ, Terporten PH, Sillekens P, Lukacsi A, Van Hooff JP, Bruggeman CA.

J Med Virol. 2004 Jan;72(1):94-101.

PMID:
14635016
12.

Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification.

Loens K, Ieven M, Ursi D, Beck T, Overdijk M, Sillekens P, Goossens H.

J Clin Microbiol. 2003 Sep;41(9):4448-50.

13.

Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae.

Templeton KE, Scheltinga SA, Graffelman AW, Van Schie JM, Crielaard JW, Sillekens P, Van Den Broek PJ, Goossens H, Beersma MF, Claas EC.

J Clin Microbiol. 2003 Sep;41(9):4366-71.

14.

Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species.

Templeton KE, Scheltinga SA, Sillekens P, Crielaard JW, van Dam AP, Goossens H, Claas EC.

J Clin Microbiol. 2003 Sep;41(9):4016-21.

15.
16.

Application of NucliSens Basic Kit for the detection of Mycoplasma pneumoniae in respiratory specimens.

Loens K, Ieven M, Ursi D, Foolen H, Sillekens P, Goossens H.

J Microbiol Methods. 2003 Jul;54(1):127-30.

PMID:
12732431
17.

Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification.

Loens K, Ursi D, Ieven M, van Aarle P, Sillekens P, Oudshoorn P, Goossens H.

J Clin Microbiol. 2002 Apr;40(4):1339-45.

18.

Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

Deiman B, van Aarle P, Sillekens P.

Mol Biotechnol. 2002 Feb;20(2):163-79. Review.

PMID:
11876473
19.

Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus.

Greijer AE, Adriaanse HM, Kahl M, Tacken NM, Oldenburg N, Sijlmans A, van de Crommert JM, Dekkers CA, Sillekens PT, Middeldorp JM.

J Virol Methods. 2001 Aug;96(2):133-47.

PMID:
11445144
20.

Sustained virological response in chronic hepatitis C patients after a 6- and a 36-month interferon-alpha2b treatment schedule: a multicenter, randomized, controlled study.

Damen M, Weegink CJ, Mauser-Bunschoten EP, Cuypers HT, Hermus MC, Sillekens P, Haan E, van den Berg HM, Bresters D, Lelie PN, Chamuleau RA, Reesink HW.

Scand J Gastroenterol. 2001 Jan;36(1):97-104.

PMID:
11218246
21.

Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.

Witt DJ, Kemper M, Stead A, Sillekens P, Ginocchio CC, Espy MJ, Paya CV, Smith TF, Roeles F, Caliendo AM.

J Clin Microbiol. 2000 Nov;38(11):3994-9.

22.

Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.

Goossens VJ, Blok MJ, Christiaans MH, van Hooff JP, Sillekens P, Höckerstedt K, Lautenschlager I, Middeldorp JM, Bruggeman CA.

Intervirology. 1999;42(5-6):373-81.

PMID:
10702720
23.

Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture.

Goossens VJ, Blok MJ, Christiaans MH, Sillekens P, Middeldorp JM, Bruggeman CA.

Transplant Proc. 2000 Feb;32(1):155-8. No abstract available.

PMID:
10701004
24.

Sensitive detection of cytomegalovirus infection in transplant recipients using nucleic acid sequence-based amplification.

Blok MJ, Lautenschlager I, Christiaans MH, Van Hooff JP, Goossens VJ, Middeldorp JM, Sillekens P, Höckerstedt K, Bruggeman CA.

Transplant Proc. 2000 Feb;32(1):149-51. No abstract available.

PMID:
10701002
25.

Characterization of the quantitative HCV NASBA assay.

Damen M, Sillekens P, Cuypers HT, Frantzen I, Melsert R.

J Virol Methods. 1999 Sep;82(1):45-54.

PMID:
10507412
26.

Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification.

Blok MJ, Christiaans MH, Goossens VJ, van Hooff JP, Sillekens P, Middeldorp JM, Bruggeman CA.

Transplantation. 1999 May 15;67(9):1274-7.

PMID:
10342321
27.

Nucleic acid sequence-based amplification: a new technique for monitoring cytomegalovirus infection in transplant recipients.

Blok MJ, Lautenschlager I, Christiaans MH, Van Hooff JP, Goossens VJ, Middeldorp JM, Sillekens P, Ramon A, Höckerstedt K, Bruggeman CA.

Transplant Proc. 1999 Feb-Mar;31(1-2):308-9. No abstract available.

PMID:
10083120
28.

Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification.

Morré SA, Sillekens PT, Jacobs MV, de Blok S, Ossewaarde JM, van Aarle P, van Gemen B, Walboomers JM, Meijer CJ, van den Brule AJ.

Mol Pathol. 1998 Jun;51(3):149-54.

29.

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification.

Damen M, Sillekens P, Sjerps M, Melsert R, Frantzen I, Reesink HW, Lelie PN, Cuypers HT.

J Virol Methods. 1998 Jun;72(2):175-84.

PMID:
9694325
30.

Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees.

van Doorn LJ, van Hoek K, de Martinoff G, Bosman F, Stuyver L, Kos T, Frantzen I, Sillekens P, Maertens G, Quint W.

J Med Virol. 1997 Aug;52(4):441-50.

PMID:
9260695
31.

RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples.

Morré SA, Sillekens P, Jacobs MV, van Aarle P, de Blok S, van Gemen B, Walboomers JM, Meijer CJ, van den Brule AJ.

J Clin Microbiol. 1996 Dec;34(12):3108-14.

32.

Qualitative and quantitative NASBA for detection of human immunodeficiency virus type 1 and hepatitis C virus infection.

Sillekens PT.

Transplant Proc. 1996 Oct;28(5):2941-4. No abstract available.

PMID:
8908134
33.
34.

The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application.

van Gemen B, v d Wiel P, van Beuningen R, Sillekens P, Jurriaans S, Dries C, Schoones R, Kievits T.

PCR Methods Appl. 1995 Feb;4(4):S177-84. No abstract available.

35.

Immunochemical structure of the carboxy-terminal part of hepatitis B e antigen: identification of internal and surface-exposed sequences.

Sällberg M, Pushko P, Berzinsh I, Bichko V, Sillekens P, Noah M, Pumpens P, Grens E, Wahren B, Magnius LO.

J Gen Virol. 1993 Jul;74 ( Pt 7):1335-40.

PMID:
7687649
36.

Bovine immunodeficiency virus: immunochemical characterization and serological survey.

Horzinek M, Keldermans L, Stuurman T, Black J, Herrewegh A, Sillekens P, Koolen M.

J Gen Virol. 1991 Dec;72 ( Pt 12):2923-8.

PMID:
1722502
37.

Structure, chromosomal localization and evolutionary conservation of the gene encoding human U1 snRNP-specific A protein.

Nelissen RL, Sillekens PT, Beijer RP, Geurts van Kessel AH, van Venrooij WJ.

Gene. 1991 Jun 30;102(2):189-96.

PMID:
1831431
38.

Assignment of seven genes to distinct intervals on the midportion of human chromosome 19q surrounding the myotonic dystrophy gene region.

Schonk D, van Dijk P, Riegmann P, Trapman J, Holm C, Willcocks TC, Sillekens P, van Venrooij W, Wimmer E, Geurts van Kessel A, et al.

Cytogenet Cell Genet. 1990;54(1-2):15-9.

PMID:
1701111
39.

Small nuclear RNA associated proteins: autoantigens in connective tissue diseases.

Van Venrooij WJ, Sillekens PT.

Clin Exp Rheumatol. 1989 Nov-Dec;7(6):635-45. Review.

PMID:
2692895
40.

Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes.

Habets WJ, Sillekens PT, Hoet MH, McAllister G, Lerner MR, van Venrooij WJ.

Proc Natl Acad Sci U S A. 1989 Jun;86(12):4674-8.

41.

Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens.

Habets WJ, Hoet MH, Sillekens PT, De Rooij DJ, Van de Putte LB, Van Venrooij WJ.

Clin Exp Immunol. 1989 May;76(2):172-7.

42.

Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.

Sillekens PT, Beijer RP, Habets WJ, van Verooij WJ.

Nucleic Acids Res. 1989 Mar 11;17(5):1893-906.

43.

Human U1 snRNP-specific C protein: complete cDNA and protein sequence and identification of a multigene family in mammals.

Sillekens PT, Beijer RP, Habets WJ, van Venrooij WJ.

Nucleic Acids Res. 1988 Sep 12;16(17):8307-21.

44.
45.

Analysis of a cDNA clone expressing a human autoimmune antigen: full-length sequence of the U2 small nuclear RNA-associated B" antigen.

Habets WJ, Sillekens PT, Hoet MH, Schalken JA, Roebroek AJ, Leunissen JA, van de Ven WJ, van Venrooij WJ.

Proc Natl Acad Sci U S A. 1987 Apr;84(8):2421-5.

46.

A model for the excision of introns 1 and 2 from adenoviral major late pre-messenger RNAs.

Mariman EC, Sillekens PT, van Beek-Reinders RJ, van Venrooij WJ.

J Mol Biol. 1984 Sep 5;178(1):47-62.

PMID:
6207303
47.

On the association of mRNA with the cytoskeleton in uninfected and adenovirus-infected human KB cells.

van Venrooij WJ, Sillekens PT, van Eekelen CA, Reinders RJ.

Exp Cell Res. 1981 Sep;135(1):79-91. No abstract available.

PMID:
7286081

Supplemental Content

Loading ...
Support Center